Overview

Risperidone for Treatment of Cocaine Dependence in Outpatients - 12

Status:
Completed
Trial end date:
1998-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to evaluate pharmacological efficacy and clinical safety of risperidone in the treatment of cocaine and amphetamine dependence.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Cocaine
Risperidone
Criteria
Inclusion Criteria:

M/F ages 21-50 . Meet DSM-IV criteria for cocaine dependence. Agree to conditions of the
study and sign informed consent.

Exclusion Criteria:

Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or
nuring women. Dependence on ETOH or benzodiazepines or other sedative/hypnotics. Acute
hepatitis. Other medical condtions that deem participation to be unsafe.